NEFL and early-onset autosomal dominant Alzheimer disease: It has proven effective in distinguishing Alzheimer’s Disease patients from healthy individuals by quantifying serum NfL levels, showcasing its potential as a cost-effective, ultra-sensitive tool for the early screening of neurodegenerative diseases.